Effects of sprint interval versus combined aerobic and resistance training in overweight women with type 2 diabetes

Not Applicable

• Conditions: Type 2 diabetes.; Non-insulin-dependent diabetes mellitus

• Registration Number: IRCT20141118019995N10
• Lead Sponsor: Vice chancellor for research, Shahrekord University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Female 45 - 60 years old with type 2 diabetes
BMI>30 kg/m2
HbA1C = 6.5%
Fasting blood glucose = 126 mg/dL
Sedentary

Exclusion Criteria

Blood pressure = 160/100 mmHg
Fasting triglyceride = 500 mg/dL
A history of cardiovascular diseases, thyroid disorder, cancer, hormonal disorder, kidney and liver diseases
Smoking, use of opioids, alcohol
Doing regular exercise more than one year

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
IL-15. Timepoint: Before and after 10 weeks of intervention. Method of measurement: ELISA kit for IL-15.;SPARC. Timepoint: Before and after 10 weeks of intervention. Method of measurement: ELISA kit for SPARC.;Irisin. Timepoint: Before and after 10 weeks of intervention. Method of measurement: ELISA kit for Irisin.;FGF-21. Timepoint: Before and after 10 weeks of intervention. Method of measurement: ELISA kit for FGF-21.;ANGPTL4. Timepoint: Before and after 10 weeks of intervention. Method of measurement: ELISA kit for ANGPTL4.

Secondary Outcome Measures

Name	Time	Method
Weight. Timepoint: Before and after 10 weeks of intervention. Method of measurement: digital scale.;Body fat percent. Timepoint: Before and after 10 weeks of intervention. Method of measurement: Caliper.;Body Mass Index (BMI). Timepoint: Before and after 10 weeks of intervention. Method of measurement: Weight divided by height squared.;Fasting blood glucose. Timepoint: Before and after 10 weeks of intervention. Method of measurement: ELISA kit.;Ansulin. Timepoint: Before and after 10 weeks of intervention. Method of measurement: ELISA kit.;Insulin resistance. Timepoint: Before and after 10 weeks of intervention. Method of measurement: The insulin resistance index by the (HOMA-IR) formula.